Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
About this item
Full title
Author / Creator
Schlaff, William D , Ackerman, Ronald T , Al-Hendy, Ayman , Archer, David F , Barnhart, Kurt T , Bradley, Linda D , Carr, Bruce R , Feinberg, Eve C , Hurtado, Sandra M , Kim, JinHee , Liu, Ran , Mabey, R. Garn , Owens, Charlotte D , Poindexter, Alfred , Puscheck, Elizabeth E , Rodriguez-Ginorio, Henry , Simon, James A , Soliman, Ahmed M , Stewart, Elizabeth A , Watts, Nelson B and Muneyyirci-Delale, Ozgul
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In two identical, double-blind, randomized, 6-month phase 3 trials, elagolix (an oral gonadotropin-releasing hormone antagonist), administered with hormonal add-back therapy (estradiol, 1 mg, and norethindrone acetate, 0.5 mg, once daily) was more effective in reducing heavy menstrual bleeding in women with uterine fibroids than placebo. Bone loss...
Alternative Titles
Full title
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids
Authors, Artists and Contributors
Author / Creator
Ackerman, Ronald T
Al-Hendy, Ayman
Archer, David F
Barnhart, Kurt T
Bradley, Linda D
Carr, Bruce R
Feinberg, Eve C
Hurtado, Sandra M
Kim, JinHee
Liu, Ran
Mabey, R. Garn
Owens, Charlotte D
Poindexter, Alfred
Puscheck, Elizabeth E
Rodriguez-Ginorio, Henry
Simon, James A
Soliman, Ahmed M
Stewart, Elizabeth A
Watts, Nelson B
Muneyyirci-Delale, Ozgul
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2343602415
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2343602415
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1904351
